We are updating our previous response to provide the quantitative impact of the errors on the quarterly period ended March 31, 2012. Although we did not specifically reference the fourth quarter of fiscal 2012 in the formal analysis presented, we had considered the impact in the fourth quarter, which we determined to be immaterial.
We have included in our analysis an evaluation of the quantitative and qualitative impact of the accelerated
on the fourth quarter of fiscal 2012.
Rest of the answer
Management did not rely on any one particular quantitative or qualitative factor and instead considered all relevant information in evaluating whether the amounts referenced should be considered material in accordance with ASC 250-10-45-27. We also considered the guidance in paragraph 29 of APB 28, in assessing materiality.
We note that the fourth quarter of fiscal 2012 included certain significant items that adversely impacted our fiscal 2012 fourth quarter results, which included charges to our earnings related to our acquisition of the acquired GSK brands as well as the loss on the extinguishment of debt. Due to these items, our reported results were close to break-even, which was not consistent with our trend of earnings. Accordingly, we considered these items when evaluating the materiality of the errors to the fourth quarter of fiscal 2012. When excluding such items, the impact of the accelerated amortization on income before income taxes was 5%. After considering the quantitative and qualitative impact in the context of FY'12-Q4 and full year fiscal 2012, we concluded that the impact was not material. Additionally, we considered the guidance in paragraph 29 of APB 28, and concluded that the originating error was not significant to the results for the quarter ended March 31, 2012.
The following table summarizes the quantitative impacts of the out-of-period adjustments on the fourth quarter and full year ended March 31, 2012:
(dollars in thousands)
Reported
Adjusted
Adjusted for below charges *
FY'12-Q4
FY'12 YTD
Amortization
(1,089
)
Income (loss) before income taxes
800
(289
20,382
61,157
60,068
% impact
(136
)%
377
%
(5
(2
* Our results for the fourth quarter ended March 31, 2012 were adversely affected by the presence of significantcharges that reduced income before income taxes by $20.7 million in that quarter, relating primarily to acquisition related charges, debt extinguishment charges and unsolicited proposal costs. Accordingly, removing the effect of these amounts, the impact of the change on income before income taxes for the fourth quarter of fiscal 2012 was 5%. These charges consist of the following items, which were highlighted in our earnings release for the fourth quarter ended March 31, 2012:
(In thousands)
Inventory step up charge associated with acquisitions
$
1,795
Legal and professional fees associated with acquisitions
8,142
Transition costs associated with GSK brands acquired
3,588
Unsolicited proposal costs
1,737
Loss on extinguishment of debt
5,409
Total adjustments to income before income taxes
20,671
Consistent with our conclusions in our response to prior comment 4, the qualitative factors impacting our year to date results for fiscal 2012 are also relevant to our fourth quarter as described below.
In performing the quantitative and qualitative evaluation, management relied on the following authoritative guidance:
•
ASC 250-10-S99-1, Securities and Exchange Commission SAB Topic 1M, formerly Staff Accounting Bulletin 99, “Materiality”
ASC 250-10-S99-2, Securities and Exchange Commission SAB Topic 1N, formerly Staff Accounting Bulletin 108, “Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements”
ASC 250-10-05, formerly Financial Accounting Standards Statement Number 154, “Accounting Changes and Error Corrections - A Replacement of APB Opinion No. 20 and FAS Statement No. 3”
We also note that the amount related to the quarter ended March 31, 2012 is non-cash, and the write-off was triggered by continued positive cash flow of the Company allowing us to make additional voluntary payments on our debt. We also considered the following additional qualitative considerations:
The error was a non-cash charge to interest expense.
The error did not materially affect a trend in earnings or earnings growth, and had no effect on income from operations. There was no impact to segment reporting and the item would not change income to a loss or vice-versa, except for FY'12-Q4, which would occur only due to the significant charges detailed above that occurred in the fourth quarter. Absent these significant charges, our results are more consistent and comparable with our prior earnings trends.
We believe that investors typically do not focus as much on non-cash related charges in their expectations, and that this error would not impact our earnings trends.
We also believe that analysts following our Company focus more on the operating performance of the brands rather than the non-cash charges recorded on our debt, especially when exhibiting strong cash flow performance. Additionally, we would not have failed to meet or beat analysts' expectations if such amounts were recorded in the prior periods. The impact of this error was 5% after removing the significant charges described above.
There was no significant change to our debt covenants. The Company would have clearly passed both before and after the slight adjustment to the interest coverage covenant.
Based on all of the relevant information, including the above qualitative considerations, and as outlined in our updated materiality memorandum provided supplementally to the Staff, management concluded that the preponderance of information supported our conclusion that the error was not material to the fourth quarter ended March 31, 2012.
As requested by the Staff, we have updated our materiality memorandum to include the fourth quarter of fiscal 2012. Our updated materiality memorandum is being provided to the Staff under separate cover by counsel to the Registrant on a confidential and supplemental basis pursuant to Rule 12b-4 under the Exchange Act of 1934, as amended. In accordance with Rule 12b-4, the Registrant requests that these materials be returned to the Registrant promptly following completion of the Staff's review thereof. By separate letter, counsel to the Registrant also has requested confidential treatment of these materials pursuant to 17 C.F.R. § 200.83.